Adaptimmune Therapeutics Plc (ADAPY)
0.026
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Adaptimmune Therapeutics Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 29.51M |
| September 04, 2026 | 29.72M |
| September 03, 2026 | 29.51M |
| September 02, 2026 | 29.25M |
| September 01, 2026 | 29.78M |
| August 31, 2026 | 28.58M |
| August 28, 2026 | 30.04M |
| August 27, 2026 | 30.28M |
| August 26, 2026 | 29.63M |
| August 25, 2026 | 29.25M |
| August 24, 2026 | 29.40M |
| August 21, 2026 | 29.78M |
| August 20, 2026 | 29.78M |
| August 19, 2026 | 29.78M |
| August 18, 2026 | 29.43M |
| August 17, 2026 | 30.31M |
| August 14, 2026 | 30.31M |
| August 13, 2026 | 29.78M |
| August 12, 2026 | 30.31M |
| August 11, 2026 | 30.57M |
| August 10, 2026 | 30.04M |
| August 07, 2026 | 30.57M |
| August 06, 2026 | 30.84M |
| August 05, 2026 | 29.91M |
| August 04, 2026 | 31.10M |
| Date | Value |
|---|---|
| August 03, 2026 | 30.31M |
| July 31, 2026 | 31.05M |
| July 30, 2026 | 31.63M |
| July 29, 2026 | 31.10M |
| July 28, 2026 | 31.37M |
| July 27, 2026 | 30.57M |
| July 24, 2026 | 30.36M |
| July 23, 2026 | 31.51M |
| July 22, 2026 | 30.17M |
| July 21, 2026 | 30.57M |
| July 20, 2026 | 31.37M |
| July 17, 2026 | 33.09M |
| July 16, 2026 | 33.14M |
| July 15, 2026 | 30.01M |
| July 14, 2026 | 31.37M |
| July 13, 2026 | 29.93M |
| July 10, 2026 | 31.37M |
| July 09, 2026 | 32.56M |
| July 08, 2026 | 32.16M |
| July 07, 2026 | 32.16M |
| July 06, 2026 | 32.96M |
| July 02, 2026 | 32.96M |
| July 01, 2026 | 32.16M |
| June 30, 2026 | 32.29M |
| June 29, 2026 | 33.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Oxford Biomedica Plc | -- |
| Kiniksa Pharmaceuticals International Plc | 5.494B |
| Autolus Therapeutics Plc | 726.29M |
| Bicycle Therapeutics Plc | -284.27M |
| Barinthus Biotherapeutics Plc | -19.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.72M |
| Revenue (Quarterly) | 13.85M |
| Total Expenses (Quarterly) | 44.56M |
| EPS Diluted (Quarterly) | -0.1163 |